These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2111137)

  • 21. Studies on the procurement of coagulation factor VIII: selective precipitation of factor VIII with hydrophilic polymers.
    Farrugia A; Griffin B; Pepper D; Prowse C
    Thromb Haemost; 1984 Jul; 51(3):338-42. PubMed ID: 6437004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate.
    Allersma DP; Smid WM; van der Does JA; van der Meer J; Briët E
    Thromb Haemost; 1996 Feb; 75(2):261-6. PubMed ID: 8815573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological alterations in haemophiliacs treated with lyophilized Factor VIII cryoprecipitate from volunteer donors.
    Ceuppens JL; Vermylen J; Colaert J; Desmyter J; Gautama K; Stevens E; The AL; Vanham G; Vermylen C; Verstraete M
    Thromb Haemost; 1984 Apr; 51(2):207-11. PubMed ID: 6429883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of fresh frozen plasma in surgery with special reference to autologous fresh frozen plasma].
    Heim MU; Mempel W
    Infusionstherapie; 1990 Apr; 17 Suppl 2():34-6. PubMed ID: 2373546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients].
    Briët E; Mauser-Bunschoten EP
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2566-71. PubMed ID: 9555158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors impeding efficient expression of factor VIII complementary DNA minigenes.
    Hoeben RC; Fallaux FJ; Schagen FH; van der Eb MM; van Ormondt H; van der Eb A
    Blood Coagul Fibrinolysis; 1997 Dec; 8 Suppl 2():S15-21. PubMed ID: 9607109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Back to the future: a recent history of haemophilia treatment.
    Mannucci PM
    Haemophilia; 2008 Jul; 14 Suppl 3():10-8. PubMed ID: 18510516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulation parameters of thawed fresh-frozen plasma during storage at different temperatures.
    Lamboo M; Poland DC; Eikenboom JC; Harvey MS; Groot E; Brand A; de Vries RR
    Transfus Med; 2007 Jun; 17(3):182-6. PubMed ID: 17561859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acquired hemophilia A as a cause of postoperative bleeding].
    Leimkühler K; Bach F; Kobert K; Korth M; Schmidt B; Kulbe C; Gummelt I; Mertzlufft F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 May; 38(5):359-65. PubMed ID: 12712401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Collection and utilization of plasma in Austria: on the way to national self-sufficiency].
    Bergmann H; Lukas M; Prusa P
    Beitr Infusionsther Transfusionsmed; 1996; 33():103-10. PubMed ID: 8974681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A higher than expected incidence of factor VIII inhibitors in multitransfused haemophilia A patients treated with an intermediate purity pasteurized factor VIII concentrate.
    Peerlinck K; Arnout J; Gilles JG; Saint-Remy JM; Vermylen J
    Thromb Haemost; 1993 Feb; 69(2):115-8. PubMed ID: 8456422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing factor VIII activity in frozen plasma.
    Swärd-Nilsson AM; Persson PO; Johnson U; Lethagen S
    Vox Sang; 2006 Jan; 90(1):33-9. PubMed ID: 16359353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG
    Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate.
    Peerlinck K; Arnout J; Di Giambattista M; Gilles JG; Laub R; Jacquemin M; Saint-Remy JM; Vermylen J
    Thromb Haemost; 1997 Jan; 77(1):80-6. PubMed ID: 9031454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evolution of indications and consumptions of fresh frozen plasma from 1997 to 2003 in a teaching Hospital].
    Boulat C; Clero B
    Transfus Clin Biol; 2005 Jul; 12(3):251-6. PubMed ID: 15953748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of segments for the quality control of the factor VIII: coagulant activity of fresh frozen plasma.
    Ofosu FA; Blajchman MA; Kaegi A; Turc JM
    Vox Sang; 1985; 48(4):213-6. PubMed ID: 3920830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryoprecipitated anti-hemophiliac factor manufactured from plasma frozen within 24 h after phlebotomy meets AABB quality standards.
    Lokhandwala PM; Young PP; White J; Brown BL
    Transfusion; 2022 Sep; 62(9):1731-1735. PubMed ID: 35894539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The plasma supply in Germany.
    Moog R
    Transfus Apher Sci; 2019 Dec; 58(6):102668. PubMed ID: 31753775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor VIII supply and demand.
    Jones P
    Br Med J; 1980 Jun; 280(6230):1531-2. PubMed ID: 6770954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.